Market Tracker

03/23 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

14.40
Delayed Data
As of 3:59pm ET
 +0.25 / +1.77%
Today’s Change
12.21
Today|||52-Week Range
25.46
+9.92%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close14.15
Today’s open14.15
Day’s range13.95 - 14.70
Volume581,983
Average volume (3 months)956,991
Market cap$758.1M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-54.76%
Earnings growth (this year)+19.66%
Earnings growth (next 5 years)+19.21%
Revenue growth (last year)--
P/E ratioNM
Price/Sales388.44
Price/Book--

Competitors

----
ZIOPZIOPHARM Oncology In...+0.06+1.03%
ACRSAclaris Therapeutics...+0.62+2.09%
LCILannett Company Inc+0.35+1.68%
Data as of 4:01pm ET, 03/23/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$1.3M
Annual profit (last year)-$173.1M
Net profit margin-13,537.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts